Delivery Order SPE2DB22D1106-SPE2DB25FFGR8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract valued at $27,672.52. This delivery order is expected to be completed by August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120 count) with a ceiling value of $8,896.41. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by September 12, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,896.41 to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120 count) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract valued at $8,896.41. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) valued at $8,896.41, with an ultimate completion date of September 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- This delivery order for $6,160.65, awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, is for 120 capsules of the cancer drug Tafinlar at 50 mg each. The place of performance is Conshohocken, Pennsylvania and the period of performance concludes on October 31, 2023. No set-aside designation was used for this firm fixed price contract. As the Defense Logistics Agency Troop Support Medical supports the healthcare needs of military members, this order for an...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $14,281.08 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 120 capsules of Tafinlar, a prescription medication used to treat certain types of skin cancer and lung cancer, to locations within the Conshohocken, Pennsylvania area. The order is funded by the Defense Logistics Agency and supports the agency's medical supply needs. Amerisourcebergen, a subsidiary of...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $6,160.65 to supply 120 capsules of TAFINLAR 50 MG CAPSULE. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all supplies to be delivered by December 29, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with no set-aside designation specified. As a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 120 capsules of the pharmaceutical drug TAFINLAR 75 mg. The $8,139.33 contract has a completion date of February 7, 2024 and was awarded on January 17, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and related distribution services to DLA Troop Support Medical under similar contracts...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $8,139.33, is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a type of prescription pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 9, 2024. This award is part of a larger Indefinite Delivery Contract...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGR8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) with a ceiling value of $13,836.26. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs and enables AmerisourceBergen to deliver a wide range of pharmaceutical products, including specialty medications and brand-name drugs, to the Defense Health Agency and other federal healthcare systems. The Tafinlar supply under this order supports the military's medical supply requirements as part of DLA's broader pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 9/3/25 |